The aim of the work was to assess the quality of life in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate or methotrexate monotherapy. The statistically significant improvement of quality of life in both groups 12 months after onset of the treatment was roughly identical. Rutiximab was prescribed after ineffective treatment with TNF-α inhibitors.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
quality life
12
life patients
8
patients rheumatoid
8
rheumatoid arthritis
8
arthritis treated
8
[the quality
4
treated rituximab]
4
rituximab] aim
4
aim work
4
work assess
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!